313 related articles for article (PubMed ID: 33918002)
1. Krüppel-Like Factor 4 and Its Activator APTO-253 Induce NOXA-Mediated, p53-Independent Apoptosis in Triple-Negative Breast Cancer Cells.
Nakajima W; Miyazaki K; Asano Y; Kubota S; Tanaka N
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918002
[TBL] [Abstract][Full Text] [Related]
2. Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.
Torres-Adorno AM; Lee J; Kogawa T; Ordentlich P; Tripathy D; Lim B; Ueno NT
Clin Cancer Res; 2017 Aug; 23(16):4780-4792. PubMed ID: 28465444
[No Abstract] [Full Text] [Related]
3. p53-independent Noxa induction by cisplatin is regulated by ATF3/ATF4 in head and neck squamous cell carcinoma cells.
Sharma K; Vu TT; Cook W; Naseri M; Zhan K; Nakajima W; Harada H
Mol Oncol; 2018 Jun; 12(6):788-798. PubMed ID: 29352505
[TBL] [Abstract][Full Text] [Related]
4. KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene.
Roberts MS; Anstine LJ; Finke VS; Bryson BL; Webb BM; Weber-Bonk KL; Seachrist DD; Majmudar PR; Keri RA
Breast Cancer Res; 2020 Jun; 22(1):66. PubMed ID: 32552913
[TBL] [Abstract][Full Text] [Related]
5. Noxa induces apoptosis in oncogene-expressing cells through catch-and-release mechanism operating between Puma and Mcl-1.
Nakajima W; Tanaka N
Biochem Biophys Res Commun; 2011 Oct; 413(4):643-8. PubMed ID: 21945433
[TBL] [Abstract][Full Text] [Related]
6. KLF4 and NANOG are prognostic biomarkers for triple-negative breast cancer.
Nagata T; Shimada Y; Sekine S; Moriyama M; Hashimoto I; Matsui K; Okumura T; Hori T; Imura J; Tsukada K
Breast Cancer; 2017 Mar; 24(2):326-335. PubMed ID: 27300169
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis regulator Bcl-2 is an independent prognostic marker for worse overall survival in triple-negative breast cancer patients.
Ozretic P; Alvir I; Sarcevic B; Vujaskovic Z; Rendic-Miocevic Z; Roguljic A; Beketic-Oreskovic L
Int J Biol Markers; 2018 Jan; 33(1):109-115. PubMed ID: 28777433
[TBL] [Abstract][Full Text] [Related]
8. NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer.
Liu RZ; Vo TM; Jain S; Choi WS; Garcia E; Monckton EA; Mackey JR; Godbout R
J Pathol; 2019 Feb; 247(2):186-198. PubMed ID: 30350349
[TBL] [Abstract][Full Text] [Related]
9. Sall2 is required for proapoptotic Noxa expression and genotoxic stress-induced apoptosis by doxorubicin.
Escobar D; Hepp MI; Farkas C; Campos T; Sodir NM; Morales M; Álvarez CI; Swigart L; Evan GI; Gutiérrez JL; Nishinakamura R; Castro AF; Pincheira R
Cell Death Dis; 2015 Jul; 6(7):e1816. PubMed ID: 26181197
[TBL] [Abstract][Full Text] [Related]
10. Role of Noxa in p53-independent fenretinide-induced apoptosis of neuroectodermal tumours.
Armstrong JL; Veal GJ; Redfern CP; Lovat PE
Apoptosis; 2007 Mar; 12(3):613-22. PubMed ID: 17216584
[TBL] [Abstract][Full Text] [Related]
11. MG132 induced apoptosis is associated with p53-independent induction of pro-apoptotic Noxa and transcriptional activity of beta-catenin.
Jüllig M; Zhang WV; Ferreira A; Stott NS
Apoptosis; 2006 Apr; 11(4):627-41. PubMed ID: 16673057
[TBL] [Abstract][Full Text] [Related]
12. A p38(MAPK)/HIF-1 pathway initiated by UVB irradiation is required to induce Noxa and apoptosis of human keratinocytes.
Nys K; Van Laethem A; Michiels C; Rubio N; Piette JG; Garmyn M; Agostinis P
J Invest Dermatol; 2010 Sep; 130(9):2269-76. PubMed ID: 20393480
[TBL] [Abstract][Full Text] [Related]
13. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
[TBL] [Abstract][Full Text] [Related]
14. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
[TBL] [Abstract][Full Text] [Related]
15. CB002, a novel p53 tumor suppressor pathway-restoring small molecule induces tumor cell death through the pro-apoptotic protein NOXA.
Hernandez-Borrero LJ; Zhang S; Lulla A; Dicker DT; El-Deiry WS
Cell Cycle; 2018; 17(5):557-567. PubMed ID: 28749203
[TBL] [Abstract][Full Text] [Related]
16. Synergistic induction of apoptosis by p53-inducible Bcl-2 family proteins Noxa and Puma.
Nakajima W; Tanaka N
J Nippon Med Sch; 2007 Apr; 74(2):148-57. PubMed ID: 17507791
[TBL] [Abstract][Full Text] [Related]
17. KLF4 expression enhances the efficacy of chemotherapy drugs in ovarian cancer cells.
Wang B; Shen A; Ouyang X; Zhao G; Du Z; Huo W; Zhang T; Wang Y; Yang C; Dong P; Watari H; Pfeffer LM; Yue J
Biochem Biophys Res Commun; 2017 Mar; 484(3):486-492. PubMed ID: 28108288
[TBL] [Abstract][Full Text] [Related]
18. 5-Aza-2'-deoxycytidine restores proapoptotic function of p53 in cancer cells resistant to p53-induced apoptosis.
Yagi S; Oda-Sato E; Uehara I; Asano Y; Nakajima W; Takeshita T; Tanaka N
Cancer Invest; 2008 Aug; 26(7):680-8. PubMed ID: 18608210
[TBL] [Abstract][Full Text] [Related]
19. PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation.
Furukawa H; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Cancer Sci; 2018 Feb; 109(2):412-421. PubMed ID: 29168598
[TBL] [Abstract][Full Text] [Related]
20. Integral role of Noxa in p53-mediated apoptotic response.
Shibue T; Takeda K; Oda E; Tanaka H; Murasawa H; Takaoka A; Morishita Y; Akira S; Taniguchi T; Tanaka N
Genes Dev; 2003 Sep; 17(18):2233-8. PubMed ID: 12952892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
